ALBANY, New York, May 19, 2020 /PRNewswire/ -- The Global Hospital Acquired Disease Testing Market is expected to chart a stellar growth curve over the period 2019 to 2027, owing to multiple reasons – the most prominent among which is the increase in incidence of reported cases of hospital acquired infections. The compound annual growth rate of the market would be 14.7%.
Transparency Market Research opines, "Increasingly used by healthcare professionals, particularly in clinical laboratories, these testing solutions are witnessing growth in demand due to longer stays of patients in hospitals – something the governments are trying to fix world over using technology. Awareness regarding nosocomial infections is also leading to growth in the global hospital acquired disease testing market over the stated forecast period." Read Detailed TOC of the Report - https://www.transparencymarketresearch.com/report-toc/1759
Key Findings of Global Hospital Acquired Disease Testing Market Study:
Owing to high prevalence, Urinary Tract Infections will drive significant demand for testing solutions in the market
North America will account for a sizeable share of the global hospital acquired disease testing market over the forecast period
Increase in market worth would be noted in the period; it will pave way for emergence of untapped opportunities
Key Drivers of Growth in Global Hospital Acquired Disease Testing Market:
A slew of growth factors are marking the landscape of Global Hospital Acquired Disease Testing Market, as per Transparency Market Research. The most prominent trends, drivers, and developments that are set to keep the market buoyant over the forecast period are detailed out below.
Code for prevention, , detection, and treatment of hospital acquired infections, along with established government guidelines will add to growth in the market
Nucleic acid amplification test has been recommended by Centers for Disease Control and Prevention (CDC) in order to detect C. difficile
Two-step detection prevention process is recommended by European Society of Clinical Methodology to detect C. difficile
Growing prevalence of drug resistant pathogens and increase in incidence of HAI are major factors of growth in the market
Development of sophisticated testing solutions – faster and more accurate - will propel the market on to a higher growth trajectory
Regional Analysis of Global Hospital Acquired Disease Testing Market:
North America to dominate Global Hospital Acquired Disease Testing Market due to increase in geriatric population and robust healthcare infrastructure
Europe to follow North America in terms of market share owing to presence of strong measures taken by government authorities and healthcare professionals
High prevalence of hospital acquired infections to drive growth in the Asia Pacific (APAC) region
Analyze Hospital Acquired Disease Testing Market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study
Competitors Landscape of Global Hospital Acquired Disease Testing Market:
The vendors' landscape of Global Hospital Acquired Disease Testing Market is fragmented and competitive. Top players in the market that are also profiled by Transparency Market Research in its report include Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, F, Hoffmann-La Roche Ltd, Hologic, Inc, Siemens Healthcare, Diatherix Laboratories, Inc., Meridian Bioscience, Inc., and Thermo Fisher Scientific, Inc., among others. The report prepared by Transparency Market Research is a comprehensive analysis of product portfolio, company overview, business strategies, financial overview, and recent developments.
The global hospital acquired disease testing market has been segmented as follows:
Global Hospital acquired disease testing Market, by Test Type
Urinary Tract Infection
· Global Hospital acquired disease testing Market, by Region
Rest of Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:
Nosocomial Infection Treatment Market - Rise in prevalence of nosocomial infections such as urinary tract infection, tuberculosis, surgical wound infection, and respiratory tract infection is anticipated to fuel the growth of the global market. According to the Pharmacotherapy Self-Assessment Program: Hematology/Oncology, approximately 60% of women have symptomatic UTI during their lifetime and in the U.S., around 10% women have one or more than one UTI episodes each year. According to the World Health Organization, globally, an estimated 10 million people fell ill with tuberculosis in 2018. According to the Centers for Disease Control and Prevention, around 157,500 surgical site infections are reported in the U.S. each year.
COVID-19 Detection Kits Market - The growth of the global covid-19 detection kits market relies on the responsiveness of countries to contain the spread of the coronavirus. The pandemic has wreaked havoc across the healthcare industry, and has led medical researchers to redirect all their might towards developing test kits and antidotes for coronavirus. The World Health Organization (WHO) declared the coronavirus as a global health emergency, following an outbreak of cases in several parts of the world. Currently, more than 180 countries have reported cases of coronavirus in individuals of all age groups.
Respiratory Antiviral Treatment Market - Rise in prevalence of viral respiratory infections in humans and increase in health care expenditure are projected to boost the growth of the global respiratory antiviral treatment market during the forecast period. Respiratory syncytial virus, influenza virus, parainfluenza virus, adenovirus, rhinovirus, and coronavirus belong to the respiratory virus infections group. Increase in number of patients with influenza, coronavirus, upper respiratory tract infections (URTI), and pneumonia is anticipated to fuel the growth of the global respiratory antiviral treatment market from 2020 to 2030. According to the World Health Organization, around 1.9 million people are suffering from coronavirus and 123,126 confirmed death due to coronavirus were recorded to date.
Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.